Перейти к содержанию 
Pharmaceutical production losses do not come only from major equipment failures. А таблеточный пресс can remain in operation while unstable feeding reduces output. А блистерная упаковочная машина can run for most of a shift yet lose capacity through repeated short stops, empty cavities, or sealing defects. A tablet capsule counting line can count accurately but still miss its target when the capping or cartoning section becomes the bottleneck.
Overall equipment effectiveness, commonly shortened to OEE, measures how effectively planned production time is converted into acceptable output at a defined operating rate. It combines three factors: availability, производительность, и качество.
By separating downtime, speed loss, and rejected output, OEE helps production teams identify where capacity is being lost. Its value does not lie in producing a high percentage alone, but in directing attention toward recurring losses that can be investigated and improved.
What Is Overall Equipment Effectiveness in Pharmaceutical Manufacturing?
Overall equipment effectiveness measures the proportion of planned production time that produces acceptable units at the defined production rate.
OEE = Availability × Performance × Quality
Each factor represents a different production loss.
| OEE factor | What it measures | Typical losses |
| Availability | Whether equipment was running during planned production time | Breakdowns, long adjustments, переналадки, material waiting, and extended stops |
| Производительность | Whether equipment produced at the defined rate while running | Minor stops, нестабильное питание, reduced speed, upstream starvation, and downstream blockage |
| Качество | How much output met the acceptance criteria | Startup rejects, поврежденные продукты, incomplete packs, incorrect counts, and sealing defects |
Iso 22400 provides a framework for defining manufacturing operations KPIs and their calculation elements. OEE is therefore a manufacturing performance indicator, not a product-release criterion or evidence that a machine complies with GMP. ICH Q10 places process-performance and product-quality monitoring within a wider pharmaceutical quality system, but it does not establish a universal OEE target.
Availability
Availability compares actual run time with planned production time:
Availability = Run Time ÷ Planned Production Time
The calculation depends on a consistent definition of planned production time. A manufacturer should define how scheduled breaks, preventive maintenance, уборка, line clearance, переналадки, and periods without a production order are treated. Changing these rules between reports creates misleading comparisons.
Required cleaning and quality activities should not be shortened to improve the score. Teams should instead investigate avoidable delays around those activities, such as missing tools, unavailable change parts, late material preparation, or poor coordination between departments.
Производительность
Performance compares actual output with the output expected during recorded run time:
Performance = Actual Output ÷ Expected Output During Run Time
A machine can lose performance without a long stop. Repeated interruptions lasting only a few seconds can remove substantial output from a shift. Examples include inconsistent capsule separation in a Машина для наполнения капсул, product-feeding gaps on a blister packaging machine, fallen bottles on a conveyor, or cartons that fail to open correctly.
The reference rate must be realistic and consistent. The maximum speed in an equipment specification is not automatically appropriate for every product. Размер капсулы, поток порошка, tablet dimensions, формат упаковки, материальное поведение, inspection settings, and downstream capacity affect the speed a process sustains reliably.
Using an unrealistic maximum makes performance appear artificially low. Reducing the reference whenever output falls hides genuine losses. The site should define a defensible rate for each product and format under normal operating conditions.
Качество
Quality compares acceptable output with total output:
Quality = Good Count ÷ Total Count
Quality losses include rejects generated during startup and normal production. On a blister line, they include empty cavities, damaged packs, incomplete seals, or incorrect cutting. На tablet and capsule counting line, they include incorrect quantities, отсутствуют шапки, failed seals, or packs removed during downstream inspection.
A rejected unit does not automatically prove that one machine caused the defect. Product condition, incoming materials, настройки процесса, inspection limits, equipment condition, and operator adjustments all belong in the root-cause analysis.
How Is OEE Calculated on a Pharmaceutical Packaging Line?
Consider a blister packaging and cartoning line operating during an eight-hour shift. After scheduled breaks and planned non-production activities are excluded, the line has 450 minutes of planned production time.
- Planned production time: 450 минуты
- Recorded downtime: 45 минуты
- Run time: 405 минуты
- Defined production rate: 200 блистерных упаковок в минуту
- Total output: 72,900 пакеты
- Good output: 71,442 пакеты
Availability is:
405 ÷ 450 = 90%
Expected output during 405 minutes is 81,000 пакеты, so performance is:
72,900 ÷ 81,000 = 90%
Quality is:
71,442 ÷ 72,900 = 98%
The final OEE is:
90% × 90% × 98% = 79.4%
The three component scores show that quality is relatively strong, while availability and performance create larger losses. That does not prove maintenance is the only priority. The 45 minutes of downtime must first be divided into breakdowns, format changes, задержки с уборкой, material waiting, and adjustment time.
The performance score also needs context. It can result from a steady reduction in speed, frequent short stops, или оба. Alarm histories, machine counters, downtime records, информация о партии, and operator observations are needed to turn the percentage into a useful investigation.
Where Does OEE Loss Occur in Pharmaceutical Manufacturing?
The traditional six-loss model is useful when each category reflects the actual process.
1. Equipment Breakdowns
Механический, electrical, пневматический, контроль, and sensor failures reduce availability. Analysis should consider both duration and recurrence. A short fault repeated every shift can remove more annual output than one isolated breakdown.
2. Setup and Adjustment
Changeovers, tooling replacement, format-part changes, настройка параметров, уборка, and line clearance can occupy planned production time. Many of these activities are necessary. Improvement should focus on preparation, task sequence, tool organization, проверка, and handover rather than bypassing required controls.
3. Minor Stops
Short interruptions reduce performance and are often underreported because operators clear them quickly. Tablet bridging, capsule separation errors, blister feeding gaps, bottle accumulation, leaflet jams, and carton-opening failures are common examples.
4. Reduced Speed
A machine can remain running below the defined rate because of material variation, worn parts, нестабильное питание, conservative settings, inspection instability, or poor coordination between connected machines. Running one machine faster can reduce line output when it creates congestion or more rejects.
5. Startup Rejects
Output produced while settings stabilize after startup or changeover lowers quality. Repeatable tooling installation, parameter transfer, подготовка материала, and first-piece checks reduce this loss without weakening acceptance criteria.
6. Production Rejects
Rejects during steady operation include damaged products, incomplete blister packs, incorrect bottle counts, missing components, weak seals, and rejected cartons. Inspection data should distinguish confirmed defects from false rejections.
ICH Q10 emphasizes using process and product information to identify sources of variation and support continual improvement. OEE contributes operational data, but deviation records, quality results, maintenance history, and material information remain necessary for a complete investigation.
How Can Pharmaceutical Manufacturers Improve OEE?
Improvement should begin with the weakest OEE component and the largest recurring loss, not with a general demand for higher machine speed.
Establish Consistent Data Rules
Define planned production time, run time, total count, good count, reference speed, and stop categories before comparing equipment, products, or shifts. Automated collection reduces recording gaps, but it does not correct unclear definitions.
Prioritize Losses by Frequency and Duration
Rank downtime and minor stops by total duration and recurrence. A two-minute interruption repeated thirty times deserves more attention than one isolated twenty-minute stop. Производство, обслуживание, and engineering should use consistent fault descriptions so that one issue is not divided among several vague codes.
Improve Changeover Preparation
Changeover improvement begins before the current batch ends. Change parts should be clean, verified, полный, and positioned for use. Инструменты, documents, материалы, and inspection samples should also be ready.
Equipment design can support changeover efficiency when format parts are accessible and replacement steps are repeatable. Например, the Ruida Packing NJP-1500D automatic capsule filling machine uses a pull-out filling-rod holder and modular tooling designed to support mold changes in about 15 минуты. Actual changeover time still depends on preparation, требования к уборке, размер капсулы, operator experience, and verification procedures.
The objective is not the shortest possible changeover. It is a repeatable process that restores stable, acceptable production with fewer adjustments and fewer startup rejects.
Capture Minor Stops and Speed Loss
Machine event logs, practical operator stop codes, and shift reviews should distinguish feeding, продукт, материал, инспекция, upstream, and downstream causes. Too many categories make reporting inconsistent, while broad categories hide useful detail.
Balance the Complete Line
Machine-level improvements do not always increase saleable output. A tablet capsule counting machine can feed bottles faster than a capper can process them. A blister packaging machine can overload a Машина для упаковки в блистерную упаковку. A tablet press can produce consistently while a downstream deduster or metal detector limits transfer.
Line analysis should identify the actual constraint and measure upstream starvation, downstream blockage, buffer use, and reject flow. The most valuable improvement is often better coordination at machine interfaces rather than a higher maximum speed for one unit.
Protect Product Quality
An OEE project should not relax inspection limits, remove required checks, or shorten approved controls to increase the score. FDA quality-systems guidance places continual improvement within a wider system of process knowledge, quality responsibilities, and CGMP compliance; efficiency does not replace product quality.
When quality falls, compare defect type, время, batch, material lot, machine state, and inspection result. This separates equipment-related patterns from material, процесс, and setup problems.
Review Trends Instead of Isolated Scores
A daily score supports shift management, but process and investment decisions require trends. Compare similar products, форматы, размеры партии, and operating conditions. Review availability, производительность, and quality separately because a stable final score can hide improvement in one factor and decline in another.
Machine OEE and Production Line OEE Are Not the Same
Machine OEE measures losses within one equipment boundary. Line OEE measures acceptable output from the connected process.
A blister machine can show strong machine OEE while waiting for upstream product. A cartoning machine can record repeated stops caused by inconsistent packs arriving from the previous operation. Several machines can each report acceptable results while the complete line remains limited by one interface.
Do not calculate line OEE by averaging the OEE percentages of individual machines. Measure the line against its own planned time, defined rate, total output, and good output. Machine-level data then explains where the line loss occurred.
Заключение
Overall equipment effectiveness in pharmaceutical manufacturing separates production loss into availability, производительность, и качество. The percentage is useful only when calculation rules remain consistent and loss data leads to investigation.
OEE supports improvement when teams reduce recurring downtime, minor stops, speed imbalance, and defects without weakening process or quality controls. Equipment capability matters, but materials, методы, обслуживание, people, and line integration determine the final result together.
Часто задаваемые вопросы
Is OEE Required by GMP?
Нет. OEE is a manufacturing KPI, not a universal GMP requirement or product-release test. A company decides how to use it within its performance and improvement system.
What Is a Good OEE Score for Pharmaceutical Manufacturing?
There is no single score for every process. Тип продукта, размер партии, cleaning frequency, changeover pattern, уровень автоматизации, and calculation rules affect the result. A consistent internal baseline is more useful than an unsupported cross-industry target.
Should Cleaning and Changeover Time Be Included in OEE?
It depends on the documented definition of planned production time. The method should remain consistent across comparable reports. Required activities should not be removed or shortened simply to increase the score.
Can OEE Exceed 100%?
A correctly defined OEE should not exceed 100%. A higher result usually indicates an incorrect reference speed, time boundary, production count, or formula.
Does a Faster Machine Always Improve OEE?
Нет. Higher speed improves output only when the process remains stable and connected equipment can handle the flow. More jams, blockage, отвергает, or downtime can reduce line OEE even when one machine runs faster.
Ссылки
- Iso 22400-1 и ИСО 22400-2, Key Performance Indicators for Manufacturing Operations Management.
- Международный совет по гармонизации, ICH Q10 Pharmaceutical Quality System.
- НАС. Управление по контролю за продуктами и лекарствами, Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations.
